HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetics of 5,6-trans-25-hydroxycholecalciferol, a synthetic analogue of vitamin D3, in man.

Abstract
Vitamin D analogues of high biological activity are probably useful in the treatment of renal osteodystrophy. The pharmacokinetics of the synthetic compound 5,6-trans-25-hydroxycholecalciferol have been studied in healthy subjects who were of normal vitamin D status. In comparison to natural 25-hydroxy-cholecalciferol, serum levels of the analogue were lower and its half-life in blood after oral or intravenous administration was considerably shorter. In normal subjects no increase of dihydroxylated metabolites in serum was observed within seven days of an intravenous dose.
AuthorsG Offermann, K Schaefer, H G Grigoleit, F Dittmar
JournalEuropean journal of clinical pharmacology (Eur J Clin Pharmacol) Vol. 8 Issue 3-4 Pg. 255-60 (Apr 04 1975) ISSN: 0031-6970 [Print] Germany
PMID1233221 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Hydroxycholecalciferols
Topics
  • Administration, Oral
  • Adult
  • Female
  • Half-Life
  • Humans
  • Hydroxycholecalciferols (administration & dosage, blood)
  • Injections, Intravenous
  • Kinetics
  • Male
  • Models, Biological

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: